Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3
Study Details
Study Description
Brief Summary
A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: ReSTOR Aspheric +3 Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes). |
Device: ReSTOR
Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes).
|
Outcome Measures
Primary Outcome Measures
- Uncorrected Visual Acuity (UCVA) [6 months]
Uncorrected Visual Acuity (UCVA) measured by means of logMAR at various distances (40 centimeters (cm), 50 cm, 60 cm, 70 cm, and 4 meters (m)). Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity.
Eligibility Criteria
Criteria
Inclusion Criteria:
- Diagnosed with cataracts
Exclusion Criteria:
-
Pre-existing conditions that could skew the results or are contraindications for the ReSTOR intraocular lens;
-
<1 diopter astigmatism by keratometry readings.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Alcon Call Center for Trial Locations | Fort Worth | Texas | United States | 76134 |
Sponsors and Collaborators
- Alcon Research
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- M07-001
- NCT00762203
Study Results
Participant Flow
Recruitment Details | Subjects 18 - 70 years of age, either sex and any race. Diagnosis of cataracts in one or both eyes. |
---|---|
Pre-assignment Detail | Subject's eligibility was determined at the preoperative visit. All subjects met inclusion/exclusion criteria. |
Arm/Group Title | ReSTOR Aspheric +3 |
---|---|
Arm/Group Description | Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes). |
Period Title: Overall Study | |
STARTED | 218 |
COMPLETED | 196 |
NOT COMPLETED | 22 |
Baseline Characteristics
Arm/Group Title | ReSTOR Aspheric +3 |
---|---|
Arm/Group Description | Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes). |
Overall Participants | 218 |
Age (participants) [Number] | |
<=18 years |
0
0%
|
Between 18 and 65 years |
143
65.6%
|
>=65 years |
64
29.4%
|
Gender (participants) [Number] | |
Female |
88
40.4%
|
Male |
124
56.9%
|
Outcome Measures
Title | Uncorrected Visual Acuity (UCVA) |
---|---|
Description | Uncorrected Visual Acuity (UCVA) measured by means of logMAR at various distances (40 centimeters (cm), 50 cm, 60 cm, 70 cm, and 4 meters (m)). Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity. |
Time Frame | 6 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | ReSTOR Aspheric +3 |
---|---|
Arm/Group Description | Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes). |
Measure Participants | 196 |
UCVA at 40 cm |
0.05
(0.10)
|
UCVA at 50 cm |
-0.07
(0.15)
|
UCVA at 60 cm |
0.15
(0.14)
|
UCVA at 70 cm |
0.20
(0.13)
|
UCVA at 4 m |
-0.01
(0.11)
|
Adverse Events
Time Frame | Up to 6 months post-operative | |
---|---|---|
Adverse Event Reporting Description | Volunteered and solicited adverse events were collected from the time of surgery to the 6 month post-operative visit. | |
Arm/Group Title | ReSTOR Aspheric +3 | |
Arm/Group Description | Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes). | |
All Cause Mortality |
||
ReSTOR Aspheric +3 | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
ReSTOR Aspheric +3 | ||
Affected / at Risk (%) | # Events | |
Total | 1/196 (0.5%) | |
Eye disorders | ||
Chronic inflammation/iritis | 1/196 (0.5%) | 1 |
Other (Not Including Serious) Adverse Events |
||
ReSTOR Aspheric +3 | ||
Affected / at Risk (%) | # Events | |
Total | 0/196 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
No paper that incorporates Sponsor Condfidential information will be submitted for publication without Sponsor's prior written agreement.
Results Point of Contact
Name/Title | Alcon Clinical |
---|---|
Organization | Alcon Research, Ltd. |
Phone | 888.451.3937; 817.568.6725 |
medinfo@alconlabs.com |
- M07-001
- NCT00762203